Stock Market News

Scholar Rock stock surges on positive spinal muscular atrophy treatment data

2024.10.07 10:55

Scholar Rock stock surges on positive spinal muscular atrophy treatment data

Investing.com — Shares of Scholar Rock Holdings skyrocketed 320% on Monday following the announcement of positive results from its Phase 3 SAPPHIRE clinical trial for apitegromab, a treatment for spinal muscular atrophy (SMA).

The trial met its primary endpoint, showing statistically significant improvements in motor function as measured by the Hammersmith Functional Motor Scale Expanded (HFMSE).

Scholar Rock explained in its press release that 30.4% of patients receiving apitegromab experienced a greater than three-point improvement compared to only 12.5% of those on a placebo.

Dr. Jay Backstrom, President and CEO of Scholar Rock, expressed enthusiasm for the results, stating, “The results clearly demonstrate robust and clinically meaningful improvement in motor function in patients with SMA.”

The company plans to submit a U.S. Biologics License Application and European Union marketing authorization application in the first quarter of 2025.

The company added that was no new safety findings were observed in the SAPPHIRE clinical trial and the profile was consistent with that observed in the Phase 2 TOPAZ clinical trial.

Following the news, Truist analysts said in a note that the study showed a clinically meaningful improvement of 1.8 points compared to placebo, reinforcing the unmet need for effective SMA treatments.

They reiterated a Buy rating for Scholar Rock and increased the price target from $20 to $36 per share.

“We see this as a validation of the company’s TGFbeta platform and of their strategy to evaluate anti-myostatin (a drug that improves muscle) on top of a drug that targets the genetic cause of the disease,” said Truist.

“We also see these data as a positive read-through to the company’s obesity program with readout in 2Q2025,” they added. As a reminder, while apitegromab is being evaluated in a Ph2 trial, company plans to develop SRK-439, a next gen anti-myostatin drug that has been engineered specifically for CVD in obesity.”



Source link

Related Articles

Back to top button
bitcoin
Bitcoin (BTC) $ 72,486.42 1.69%
ethereum
Ethereum (ETH) $ 2,675.36 2.02%
tether
Tether (USDT) $ 1.00 0.11%
bnb
BNB (BNB) $ 602.79 0.55%
solana
Solana (SOL) $ 178.43 1.44%
usd-coin
USDC (USDC) $ 1.00 0.01%
xrp
XRP (XRP) $ 0.525052 0.26%
staked-ether
Lido Staked Ether (STETH) $ 2,674.99 2.04%
dogecoin
Dogecoin (DOGE) $ 0.171398 3.79%
tron
TRON (TRX) $ 0.168101 2.36%
the-open-network
Toncoin (TON) $ 5.04 0.42%
cardano
Cardano (ADA) $ 0.356579 3.03%
wrapped-steth
Wrapped stETH (WSTETH) $ 3,160.30 2.04%
shiba-inu
Shiba Inu (SHIB) $ 0.000019 1.63%
avalanche-2
Avalanche (AVAX) $ 26.35 0.98%
wrapped-bitcoin
Wrapped Bitcoin (WBTC) $ 72,309.37 1.64%
weth
WETH (WETH) $ 2,671.43 1.90%
chainlink
Chainlink (LINK) $ 11.92 3.61%
bitcoin-cash
Bitcoin Cash (BCH) $ 372.49 2.76%
polkadot
Polkadot (DOT) $ 4.18 1.19%
sui
Sui (SUI) $ 2.05 9.18%
leo-token
LEO Token (LEO) $ 6.09 1.21%
usds
USDS (USDS) $ 1.00 0.29%
litecoin
Litecoin (LTC) $ 72.45 0.30%
near
NEAR Protocol (NEAR) $ 4.34 2.67%
aptos
Aptos (APT) $ 9.89 2.47%
wrapped-eeth
Wrapped eETH (WEETH) $ 2,808.41 1.85%
uniswap
Uniswap (UNI) $ 7.99 0.91%
pepe
Pepe (PEPE) $ 0.000009 1.42%
internet-computer
Internet Computer (ICP) $ 8.09 0.66%
bittensor
Bittensor (TAO) $ 519.25 4.63%
fetch-ai
Artificial Superintelligence Alliance (FET) $ 1.30 1.37%
dai
Dai (DAI) $ 1.00 0.00%
monero
Monero (XMR) $ 164.06 0.43%
ethereum-classic
Ethereum Classic (ETC) $ 19.52 1.69%
stellar
Stellar (XLM) $ 0.096043 0.93%
blockstack
Stacks (STX) $ 1.84 1.88%
kaspa
Kaspa (KAS) $ 0.109811 7.52%
whitebit
WhiteBIT Coin (WBT) $ 19.08 0.89%
ethena-usde
Ethena USDe (USDE) $ 1.00 0.08%
dogwifcoin
dogwifhat (WIF) $ 2.59 2.64%
first-digital-usd
First Digital USD (FDUSD) $ 1.00 0.20%
polygon-ecosystem-token
POL (ex-MATIC) (POL) $ 0.333241 0.58%
okb
OKB (OKB) $ 39.27 2.10%
aave
Aave (AAVE) $ 153.48 0.41%
immutable-x
Immutable (IMX) $ 1.38 0.03%
filecoin
Filecoin (FIL) $ 3.73 2.70%
arbitrum
Arbitrum (ARB) $ 0.546887 2.82%
optimism
Optimism (OP) $ 1.72 1.89%
crypto-com-chain
Cronos (CRO) $ 0.076794 1.81%